Concepedia

ClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation

Ghassan K. Abou‐Alfa, T. Macarulla Mercadé, Milind Javle, Robin Kate Kelley, Sam Joseph Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, J.A. Bridgewater,

Annals of Oncology · 2019 · 88 citations · 0 references

DOI

Concepts